BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 379471)

  • 1. [Acute effects of bumetanide in healthy subjects. A comparative study with furosemide (author's transl)].
    Ortź González A; Méndez Martin A
    Med Clin (Barc); 1979 Mar; 72(6):259-64. PubMed ID: 379471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furosemide and bumetanide: a study of responses in normal English and German subjects.
    Branch RA; Read PR; Levine D; Elst EV; Shelton J; Rupp W; Ramsay LE
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):538-45. PubMed ID: 1277709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of the effects of furosemide, ethacrynic acid and bumetanide on the lithium clearance and diluting segment reabsorption in humans.
    Beutler JJ; Boer WH; Koomans HA; Dorhout Mees EJ
    J Pharmacol Exp Ther; 1992 Feb; 260(2):768-72. PubMed ID: 1738122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative diuretic and tissue distribution study of bumetanide and furosemide in the dog.
    Cohen MR; Hinsch E; Vergona R; Ryan J; Kolis SJ; Schwartz MA
    J Pharmacol Exp Ther; 1976 Jun; 197(3):697-702. PubMed ID: 932999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The diuretic activity of bumetanide in a controlled comparison with furosemide in patients with various degrees of impaired renal function (author's transl)].
    Kampf D; Baethke R
    Arzneimittelforschung; 1980; 30(6):1015-8. PubMed ID: 7191261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations of the early diuretic response after intravenous administration of bumetanide and furosemide in dogs.
    Olsen UB
    Acta Physiol Scand; 1975 Feb; 93(2):195-201. PubMed ID: 1146571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Result of the administration of high doses of bumetanide to patients with chronic renal failure who are on a program of hemodialysis (author's transl)].
    del Río Vázquez A; Carrera Carbó F; Arcocha Gilo V; Torrente Sierra J
    Med Clin (Barc); 1979 Jan; 72(2):71-3. PubMed ID: 431166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bumetanide, a new diuretic active during chronic renal failure (author's transl)].
    Fries D; Beroniade V; Coy JL; Delavelle F
    Pathol Biol (Paris); 1976 Jun; 24(6):435-9. PubMed ID: 785349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diuretic evaluation of bumetanide (author's transl)].
    Barrientos Guzmán A; Ortuño de Solo MT
    Med Clin (Barc); 1979 Nov; 73(8):338-41. PubMed ID: 522529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological properties of the novel highly potent diuretic 7-chloro-2,3-dihydro-1-(2-methylbenzoyl)-4(1H)-quinolinone 4-oxime-O-sulfonic acid potassium salt.
    Shinkawa T; Yamasaki F; Kikuchi A; Nakakuki M; Nishijima K; Uemura A; Mizota M; Orita Y
    Arzneimittelforschung; 1992 Dec; 42(12):1466-72. PubMed ID: 1337698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some aspects of the renal action and clinical pharmacology of oral bumetanide in man.
    Bourke E
    Postgrad Med J; 1975; 51 Suppl 6():23-26. PubMed ID: 1105529
    [No Abstract]   [Full Text] [Related]  

  • 12. Open comparison of diuretic effects of piretanide and bumetanide in patients with stable renal transplants.
    Bailey RR
    N Z Med J; 1982 Jan; 95(700):44-5. PubMed ID: 7038567
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodynamic and natriuretic effects of bumetanide and furosemide in the cat.
    Friedman PA; Roch-Ramel F
    J Pharmacol Exp Ther; 1977 Oct; 203(1):82-91. PubMed ID: 909060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of bumetanide in nephrotic syndrome: a double-blind crossover study with furosemide.
    Lau K; DeFronzo R; Morrison G; Rascoff J; Goldberg M; Agus ZS
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):489-97. PubMed ID: 789411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bumetanide and frusemide: a comparison of dose-response curves in healthy men.
    Ramsay LE; McInnes GT; Hettiarachchi J; Shelton J; Scott P
    Br J Clin Pharmacol; 1978 Mar; 5(3):243-7. PubMed ID: 656269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.
    Ohnishi A; Orita Y; Okahara R; Fujihara H; Inoue T; Yamamura Y; Yabuuchi Y; Tanaka T
    J Clin Invest; 1993 Dec; 92(6):2653-9. PubMed ID: 8254021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineral excretion following furosemide compared with bumetanide therapy in premature infants.
    Shankaran S; Liang KC; Ilagan N; Fleischmann L
    Pediatr Nephrol; 1995 Apr; 9(2):159-62. PubMed ID: 7794709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects.
    Roberts CJ; Homeida M; Roberts F; Bogie W
    Br J Clin Pharmacol; 1978 Aug; 6(2):129-33. PubMed ID: 678389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bumetanide stimulation of sodium permeability of the apical membrane of toad urinary bladder.
    Li JH; Kau ST
    J Pharmacol Exp Ther; 1988 Sep; 246(3):980-5. PubMed ID: 2843638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bumetanide, a new loop diuretic.
    Carrière S; Dandavino R
    Clin Pharmacol Ther; 1976 Oct; 20(4):424-38. PubMed ID: 788989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.